Campbell & CO Investment Adviser LLC
Position in IDXX — Idexx Laboratories Inc /De
CIK 1353570
BALTIMORE, MD
Position in IDXX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,367,009
+$3,529,465 QoQ
Shares Held
7,772
+527.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Campbell & CO Investment Adviser LLC holds $54,655,619 across 18 Diagnostics & Research names. IDXX ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
89,159 | $10,162,342 | |
| 2 | DHR |
Danaher Corp /De/
|
33,267 | $6,307,423 | |
| 3 | WAT |
Waters Corp /De/
|
16,002 | $4,765,395 | |
| 4 | GH |
Guardant Health, Inc.
|
48,547 | $4,484,286 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
This page
|
7,772 | $4,367,009 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
7,448 | $3,660,915 | |
| 7 | CSTL |
Castle Biosciences Inc
|
148,824 | $3,653,629 | |
| 8 | VCYT |
Veracyte, Inc.
|
106,443 | $3,428,529 |
All Filings in IDXX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,367,009 | 7,772 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $837,544 | 1,238 | Shares | Sole | 2026-02-12 | |
| 2025-06-30 | $2,709,053 | 5,051 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $1,215,100 | 2,939 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,464,629 | 8,837 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $4,668,774 | 8,647 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,408,716 | 2,538 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $596,436 | 1,364 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,026,055 | 2,043 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $593,594 | 1,187 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $289,651 | 710 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $488,374 | 1,499 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $319,515 | 911 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $211,712 | 387 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $597,881 | 908 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $284,830 | 458 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $889,222 | 1,408 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||